| The investment opportunity set and corporate financing, dividend, and compensation policies CW Smith Jr, RL Watts Journal of financial Economics 32 (3), 263-292, 1992 | 6029 | 1992 |
| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5704 | 2021 |
| The determinants of firms' hedging policies CW Smith, RM Stulz Journal of financial and quantitative analysis 20 (4), 391-405, 1985 | 5102 | 1985 |
| On financial contracting: An analysis of bond covenants CW Smith Jr, JB Warner Journal of financial economics 7 (2), 117-161, 1979 | 5100 | 1979 |
| The maturity structure of corporate debt MJ Barclay, CW Smith Jr the Journal of Finance 50 (2), 609-631, 1995 | 3087 | 1995 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2935 | 2020 |
| Ownership structure and voting on antitakeover amendments JA Brickley, RC Lease, CW Smith Jr Journal of financial economics 20, 267-291, 1988 | 2504 | 1988 |
| On the Determinants of Corporate Hedging DR Nance, CW Smith, CW Smithson Journal of Finance 47 (1), 267-284, 1993 | 1977 | 1993 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1781 | 2020 |
| Investment banking and the capital acquisition process CW Smith Jr Journal of financial economics 15 (1-2), 3-29, 1986 | 1677 | 1986 |
| On the corporate demand for insurance D Mayers, CW Smith Jr Foundations of Insurance Economics: Readings in Economics and Finance, 190-205, 1982 | 1276 | 1982 |
| A transactions cost approach to the theory of financial intermediation GJ Benston, CW Smith The Journal of finance 31 (2), 215-231, 1976 | 1189 | 1976 |
| Managerial Economics and Organizational Architecture, 6th Edition JA Brickley, CW Smith, JL Zimmerman McGraw-Hill/Irwin, 2016 | 1183* | 2016 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1166 | 2021 |
| Accounts receivable management policy: theory and evidence SL Mian, CW Smith Jr The journal of finance 47 (1), 169-200, 1992 | 1012 | 1992 |
| Alternative methods for raising capital: Rights versus underwritten offerings CW Smith Jr Journal of financial economics 5 (3), 273-307, 1977 | 992 | 1977 |
| The Determinants of Corporate Leverage and Dividend Policies MJ Barclay, CW Smith, RL Watts Journal of Applied Corporate Finance 7 (4), 4-19, 1995 | 968 | 1995 |
| Option pricing: A review CW Smith Jr Journal of Financial Economics 3 (1-2), 3-51, 1976 | 873 | 1976 |
| A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung … JD Cooper, M Billingham, T Egan, MI Hertz, T Higenbottam, J Lynch, ... The Journal of heart and lung transplantation: the official publication of …, 1993 | 869 | 1993 |
| Stockholder, manager, and creditor interests: Applications of agency theory MC Jensen, CW Smith Theory of the Firm 1 (1), 2000 | 800 | 2000 |
